Bio-Rad Laboratories, Inc. (BIO) Q3 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Bio-rad Laboratories, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:02.373 Ladies and gentlemen, thank you for standing by. 00:00:02.373 -- 00:00:06.137 My name is Desiree and I will be your conference operator today. 00:00:06.137 -- 00:00:11.423 At this time, I would like to welcome everyone to the BioRad 3rd Quarter 2025 Results 00:00:11.423 -- 00:00:15.967 Conference Call and Webcast. All lights have been placed on mute to prevent any background 00:00:15.967 -- 00:00:20.432 noise. After the speaker's remarks, there will be a question and answer session. 00:00:20.432 -- 00:00:25.517 If you would like to ask a question during this time, simply press star followed by 00:00:25.517 -- 00:00:30.248 the number 1 on your telephone keypad. If you would like to withdraw your question again, 00:00:30.248 -- 00:00:35.354 press the star one. I would now like to turn the conference over to Edward Chong, 00:00:35.354 -- 00:00:39.336 Head of Investor Relations. You may begin. 00:00:39.839 -- 00:00:42.883 Good afternoon, everyone, and thank you for joining us. 00:00:42.883 -- 00:00:47.929 Today, we will review the third quarter of 2025 financial results and provide an 00:00:47.929 -- 00:00:51.013 update on key business trends for Bio-Rad. 00:00:51.013 -- 00:00:56.744 With me on the call today are Norman Schwartz, our Chief Executive Officer, John DiVincenzo, 00:00:56.744 -- 00:01:02.151 President and Chief Operating Officer, and Rupalak Raju, Executive Vice President 00:01:02.151 -- 00:01:04.775 and Chief Financial Officer. 00:01:04.775 -- 00:01:09.080 Before we begin our review, I would like to remind everyone that we'll be making forward-looking 00:01:09.080 -- 00:01:14.527 statements about management's goals, plans and expectations, our future financial performance, 00:01:14.527 -- 00:01:18.772 and other matters. Th...